Gyre Therapeutics, Inc. (GYRE)
Gyre Therapeutics Market Cap : 450.76M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 450.76M |
| November 19, 2026 | 483.95M |
| November 18, 2026 | 464.68M |
| November 17, 2026 | 488.23M |
| November 16, 2026 | 470.03M |
| November 13, 2026 | 461.47M |
| November 12, 2026 | 460.40M |
| November 11, 2026 | 456.11M |
| November 10, 2026 | 452.90M |
| November 09, 2026 | 497.87M |
| November 06, 2026 | 509.65M |
| November 05, 2026 | 429.35M |
| November 04, 2026 | 475.38M |
| November 03, 2026 | 475.38M |
| November 02, 2026 | 501.54M |
| October 30, 2026 | 482.98M |
| October 29, 2026 | 679.68M |
| October 28, 2026 | 751.78M |
| October 27, 2026 | 692.40M |
| October 26, 2026 | 643.63M |
| October 23, 2026 | 620.30M |
| October 22, 2026 | 621.36M |
| October 21, 2026 | 625.60M |
| October 20, 2026 | 654.23M |
| October 19, 2026 | 645.75M |
| Date | Value |
|---|---|
| October 16, 2026 | 644.69M |
| October 15, 2026 | 678.62M |
| October 14, 2026 | 686.04M |
| October 13, 2026 | 711.49M |
| October 12, 2026 | 727.92M |
| October 09, 2026 | 746.48M |
| October 08, 2026 | 716.79M |
| October 07, 2026 | 746.48M |
| October 06, 2026 | 750.72M |
| October 05, 2026 | 779.35M |
| October 02, 2026 | 753.90M |
| October 01, 2026 | 742.24M |
| September 30, 2026 | 777.23M |
| September 29, 2026 | 776.17M |
| September 28, 2026 | 794.19M |
| September 25, 2026 | 779.35M |
| September 24, 2026 | 777.23M |
| September 23, 2026 | 784.65M |
| September 22, 2026 | 794.19M |
| September 21, 2026 | 787.83M |
| September 18, 2026 | 800.56M |
| September 17, 2026 | 761.32M |
| September 16, 2026 | 710.43M |
| September 15, 2026 | 709.37M |
| September 14, 2026 | 709.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Incyte Corp. | 23.38B |
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
Market Cap Related Metrics
| PS Ratio | 3.366 |
| PEG Ratio | -0.0089 |
| Price to Book Value | 4.176 |
| Price | 4.21 |
| Earnings Yield | -6.39% |
| PEGY Ratio | -0.0089 |